Why Kogan.com Ltd investors should be worried about Amazon

Kogan.com Ltd (ASX:KGN) CEO and founder Ruslan Kogan welcomes Amazon to Australia.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Amazon took its first scalp this week after Wesfarmers Ltd (ASX: WES) decided to shelve its plans to publicly list its stationery and offices supplies business Officeworks. The Perth-based retail conglomerate, which also owns Woolworths Limited (ASX: WOW) competitor Coles, said that soft retail conditions meant it wasn't the right time to sell out of its outperforming Officeworks business.

If management rhetoric is to be believed, Officeworks was never actively up for sale. Instead, the strategic review of the business was brought about by investment banks indicating Wesfarmers could get a good price if it sold out now.

However, with the recent profit downgrades of RCG Corporation Ltd (ASX: RCG), OrotonGroup Ltd (ASX: ORL) and slowing sales at MYER Holdings Ltd (ASX: MYR), it appears the market is fearing the worst for the retail sector in anticipation of Amazon's imminent arrival to Australia.

Accordingly, most retail stocks have plummeted as investors grow cautious of retailers' prospects.

However, one stock which continues to buck the trend is Australia's mini-rival to Amazon, Kogan.com Ltd (ASX: KGN).

About Kogan

I'm sure most readers have heard of Kogan at some point in their lives. Whether they've purchased a generic kettle from the manufacture of household appliances, or splashed out on a grey import iPhone at discounted prices (compared to Apple), most readers are likely to have visited Kogan.com at some point in their lives.

As the brainchild of former accountant and current CEO and founder – Ruslan Kogan – Kogan.com started in 2006 as a direct-to-market website where Kogan-branded goods were sourced from overseas OEM suppliers and shipped directly to customers.

Whilst purchasing from Kogan meant customers were expected to wait many weeks before their goods arrived, the direct from factory supply chain meant Kogan could substantially undercut competitors.

This business model has proven to be a resounding success – though its share price tells a different story.

Financial performance

Kogan listed on the ASX in July 2016 for $1.80 per share and has never breached that mark since. The company floated at a forward price-earnings of 20x, almost two times as expensive as bricks-and-mortar competitors JB Hi Fi Limited (ASX: JBH) and Harvey Norman Holdings Limited (ASX: HVN).

The key drawcard for investors was Kogan's exciting growth prospects as a listed company.

For the half-year ended 31 December 2016, Kogan exceeded 2017 full-year forecasts within its first half, as sales revenue swelled 37.3% on the prior corresponding period.

Pro-forma trading earnings (EBITDA) for the first half hit $7.3 million allowing the company to post margin expansion and generate a first-half net profit after tax of $3.7 million – almost 48% higher than full-year pro-forma forecasts,

Foolish takeaway

Indeed Kogan's first half was an exceptional result in the backdrop of a struggling retail environment.

However, unlike Amazon, Kogan specialises in selling generic white-label products which have been rebranded under its own name. Whilst this hasn't been a detractor to the company's success (yet), I'd imagine the introduction of Amazon's world-leading supply chain could mean branded products become cheaper, placing pressure on Kogan's margins and spelling trouble for shareholders.

Accordingly, I would stay away from Kogan shares for the time being.

Motley Fool contributor Rachit Dudhwala has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »